Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0031099 (
periodontitis
)
12,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Genetic variations contribute to the susceptibility in the development of
periodontitis
. The aim of this study was to investigate the influence of
IL18
,
IL12
, and
MMP9
polymorphisms in the chronic
periodontitis
. This case-control study involved 381 individuals matched by gender and age. Genotyping of
IL18
(rs187238 and rs1946518) and
IL12B
(rs3212227) was performed by PCR-SSP and PCR-RFLP was used for
MMP9
(rs3918242). IL-18 and MMP-9 were quantified in the serum by ELISA. SNPStats and OpenEpi software were used for statistical analysis and, in order to eliminate smoking as a confounding factor, the analyses were also performed in nonsmoking subjects. The
IL18
-137G/C genotype was associated with the risk of chronic
periodontitis
in nonsmokers (
P
c
= 0.03; OR = 1.99; overdominant inherence model). In the multivariate analyses, homozygous
IL18
-137G/G and
IL18
-607C/C were more frequent in males compared to women with these same genotypes (OR = 2.51 and OR = 3.30, respectively). The serum levels of the IL-18 in patients were higher than those in healthy controls (
P
= 0.005).
IL12B
and
MMP9
polymorphisms and MMP-9 serum concentration were similar in patients and controls. In this study,
IL18
was associated with chronic
periodontitis
susceptibility. Men had greater risk than women for developing the disease when
IL18
polymorphism was considered and the susceptibility was independent of the smoking status.
...
PMID:
IL18
Polymorphism and Periodontitis Susceptibility, Regardless of
IL12B
,
MMP9
, and Smoking Habits. 3106 35